Avalon Ventures Xi, L.P. Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Avalon Ventures Xi, L.P. is of Janux Therapeutics, Inc.. Currently has a direct ownership of 3.27 Million shares of JANX, which is worth approximately $136 Million. The most recent transaction as insider was on Jun 03, 2024, when has been sold 677,279 shares (Common Stock) at a price of $54.75 per share, resulting in proceeds of $37,081,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.27M
17.15% 3M change
25.44% 12M change
Total Value Held $136 Million

Avalon Ventures XI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
SELL
Open market or private sale
$37,081,025 $54.75 p/Share
677,279 Reduced 17.15%
3,271,216 Common Stock
Feb 29 2024
SELL
Other acquisition or disposition
-
438,722 Reduced 10.0%
3,948,495 Common Stock
Jun 15 2021
BUY
Conversion of derivative security
-
4,195,067 Added 48.88%
4,387,217 Common Stock
AVX

Avalon Ventures Xi, L.P.

La Jolla, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX